Femasys FEMY
NASDAQ FEMY
$2.78 -0.05 (-1.76%)
As of: Sep 10, 2026 · 10:35 AM EDT

Femasys (FEMY) Share-based Compensation (2020 - 2026)

Femasys' (FEMY) quarterly Share-based Compensation came in at $210820.0 in Q2 2026, down 95.21% on a YoY basis from $4.4 million in Q2 2025, and down 93.52% quarter-over-quarter from $3.3 million in Q1 2026.

Analysis

Femasys (FEMY) Share-based Compensation (2020 - 2026) Analysis & Trends

Femasys (FEMY) has reported Share-based Compensation for 7 consecutive years, with $210820.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Share-based Compensation fell 95.21% year-over-year to $210820.0; the trailing twelve-month figure through Jun 2026 stood at $411386.0 (down 90.65% YoY), and the FY2025 full-year result was $3.8 million, up 28.79% from the prior year.
  • Share-based Compensation eased to $210820.0 in Q2 2026 per FEMY's latest filing, from $3.3 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $4.4 million in Q2 2025 and bottomed at $63445.0 in Q4 2022.
  • Historically, Share-based Compensation has averaged $1.9 million across 5 years, with a median of $1.0 million in 2023.
  • The sharpest annual moves came in 2022 and 2026: Share-based Compensation jumped 1218.8% in 2022, then plunged 95.21% in 2026.
  • Over 5 years, Share-based Compensation stood at $63445.0 in 2022, then jumped by 3177.28% to $2.1 million in 2023, then slumped by 93.55% to $134143.0 in 2024, then tumbled by 50.48% to $66423.0 in 2025, then surged by 217.39% to $210820.0 in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $210820.0, $3.3 million, and $66423.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Abbott Laboratories 182.02 Bn 176.42 Bn 7.27 Bn 168.00 Mn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 67.10 Mn
3 Medtronic 117.91 Bn 109.10 Bn 6.34 Bn 125.00 Mn
4 Stryker 105.64 Bn 102.17 Bn 4.50 Bn 7.00 Mn
5 Boston Scientific 64.99 Bn 64.45 Bn 3.85 Bn 61.00 Mn
6 Edwards Lifesciences 49.92 Bn 45.67 Bn 1.35 Bn 42.20 Mn
7 Alcon 33.23 Bn 31.78 Bn 1.68 Bn 42.00 Mn
8 Dexcom 32.10 Bn 30.16 Bn 830.00 Mn 39.00 Mn
9 Steris 20.83 Bn 20.35 Bn 684.20 Mn 12.80 Mn
10 Femasys 9.33 Mn 7.89 Mn 189,391.00 210,820.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 210,820.00
Mar 31, 2026 3.25 Mn
Dec 31, 2025 66,423.00
Sep 30, 2025 4.33 Mn
Jun 30, 2025 4.40 Mn
Mar 31, 2025 4.39 Mn
Dec 31, 2024 134,143.00
Sep 30, 2024 3.00 Mn
Jun 30, 2024 2.92 Mn
Mar 31, 2024 2.75 Mn
Sep 30, 2023 2.08 Mn
Jun 30, 2023 1.02 Mn
Mar 31, 2023 886,495.00
Dec 31, 2022 63,445.00
Sep 30, 2022 971,573.00
Jun 30, 2022 950,606.00
Mar 31, 2022 955,997.00
Dec 31, 2021 22,885.00
Sep 30, 2021 696,163.00
Jun 30, 2021 699,636.00